Mark Sturmoski
Impact in
- Endocrinology top 10%
-
- Immunotherapy and Immune Responses
Papers in
- Oncology 6
- Cancer Cells and Metastasis 3
- CAR-T cell therapy research 2
- Cancer-related Molecular Pathways 1
-
- Kruppel-like factors research 1
- Co-authors
- Courtney W. Houchen (5 shared papers)Robert George (4 shared papers)Shrikant Anant (4 shared papers)Steven M. Cohn (1 shared paper)F Solomon (1 shared paper)Robert C. Lin (1 shared paper)H Ochman (1 shared paper)Eduardo A. Groisman (1 shared paper)
- Journals
- American Journal of Physiology-Gastrointestinal and Liver Physiology (4 papers)Prostaglandins & Other Lipid Mediators (1 paper)Clinical Cancer Research (1 paper)Proceedings of the National Academy of Sciences (1 paper)HPB (1 paper)
- Partner nations
- United States
In The Last Decade
Mark Sturmoski
9 papers receiving 437 citations
Peers
Comparison fields: 5 of 70
- Endocrinology 34
- Immunology 125
- Oncology 155
- Pharmacology 66
- Cancer Research 55
Countries citing papers authored by Mark Sturmoski
This map shows the geographic impact of Mark Sturmoski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sturmoski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sturmoski more than expected).
Fields of papers citing papers by Mark Sturmoski
This network shows the impact of papers produced by Mark Sturmoski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sturmoski. The network helps show where Mark Sturmoski may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Sturmoski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 109 | |
| 2 | 2014 | 75 | |
| 3 | 1993 | 65 | |
| 4 | 2007 | 61 | |
| 5 | 2003 | 56 | |
| 6 | 2021 | 52 | |
| 7 | 2008 | 20 | |
| 8 | 2006 | 12 | |
| 9 | 2020 | 3 |
About Mark Sturmoski
Mark Sturmoski is a scholar working on Oncology, Molecular Biology, Immunology, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 9 papers that have together received 453 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Cancer Cells and Metastasis (3 papers), Inflammatory mediators and NSAID effects (2 papers), CAR-T cell therapy research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Kruppel-like factors research (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Endocrinology (34 citations), Immunology (125 citations), Oncology (155 citations), Pharmacology (66 citations) and Cancer Research (55 citations). Mark Sturmoski has collaborated with scholars based in United States. Frequent co-authors include Courtney W. Houchen, Robert George, Shrikant Anant, Steven M. Cohn, F Solomon, Robert C. Lin, H Ochman, Eduardo A. Groisman, Richard Breyer and William F. Stenson. Their work appears in journals such as American Journal of Physiology-Gastrointestinal and Liver Physiology, Prostaglandins & Other Lipid Mediators, Clinical Cancer Research, Proceedings of the National Academy of Sciences and HPB.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.